AE Wealth Management LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AE Wealth Management LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$51,535
+130.3%
26,841
+72.7%
0.00%
Q2 2023$22,379
-31.4%
15,5410.0%0.00%
Q1 2023$32,636
+85.8%
15,5410.0%0.00%
Q4 2022$17,56115,5410.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders